NASDAQ

Spyre Therapeutics, Inc. (SYRE)

♥ 568 Thanks from members

Live price chart, market sentiment, and community perspectives for Spyre Therapeutics, Inc. (NASDAQ: SYRE).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Spyre Therapeutics Scientific TeamLeadership: Cameron Turtle (CEO)Leadership: Kristin DiFeo (CFO)Holder: Fairmount Funds ManagementHolder: Perceptive AdvisorsHolder: Polaris Venture PartnersSPRY-1SPRY-2Extended Half-Life Biologics for IBD#SYRE#Spyre Therapeutics#Biotech Stock#IBD Therapeutics#NASDAQ SYRE